Vestibular Incision Subperiosteal Tunnel Access With Fascia Lata Allograft in The Treatment of Gingival Recession

NCT07467096 | Completed

• 1 other identifier: KFSIRB200-93
• Study Type: interventional
• Target: 24
• Locations: 1 country
• Sites: 1

Brief Summary

The present study will be conducted as a randomized controlled clinical study to assess to evaluate the effect of minimally invasive VISTA with fascia lata allograft in the treatment of gingival recession

Conditions

Gingival Recession

Outcome Measures

Primary Outcomes (2)

• change in Gingival recession depth

  will be measured at the mid-buccal aspect of the tooth from the (CEJ) to the most apical point of the gingival margin (GM).

  2 weeks, 3 months, 6 months

• change in Gingival recession width (GRW)

  it will be measured at the mesiodistal direction of the GM at the level of CEJ

  2 weeks, 3 months, 6 months

Secondary Outcomes (6)

• change in Keratinized tissue width (KTW)

  2 weeks, 3 months, 6 months

• change in Clinical attachment loss (CAL)

  2 weeks, 3 months, 6 months

• change in Probing depth (PD)

  2 weeks, 3 months, 6 months

• change in Gingival thickness (GT)

  2 weeks, 3 months, 6 months

• change in Recession esthetic score (RES)

  2 weeks, 3 months, 6 months

Study Arms (2)

Test Group

EXPERIMENTAL

Other: Vestibular incision sub-periosteal tunnel access + fascia lata

Control Group

ACTIVE COMPARATOR

Other: Vestibular incision sub-periosteal tunnel access + subepithelial connective tissue graft

Interventions

Vestibular incision sub-periosteal tunnel access + fascia lata OTHER

The vestibular incision sub-periosteal tunnel access (VISTA) technique for all groups will be done and the patients will receive VISTA techniques with fascia lata

Test Group

Vestibular incision sub-periosteal tunnel access + subepithelial connective tissue graft OTHER

The vestibular incision sub-periosteal tunnel access (VISTA) technique for all groups will be done and the patients will receive VISTA techniques with subepithelial connective tissue graft CTG

Control Group

Eligibility Criteria

• Age: 20 Years - 50 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Presence of gingival recession type 1 (RT1) Cairo classification (6)
• Gingival recession depth ≥ 2 mm.
• Gingival thickness for the site selected should be ≥1mm.
• The height of keratinized gingiva (HKG) for the site selected should be ≥2 mm (HKG is the distance between the most apical point of the gingival margin and the mucogingival junction).
• Optimal compliance as evidenced by no missed treatment appointments and a positive attitude toward oral hygiene.

You may not qualify if:

• Presence of any systemic disease that could influence the outcome of the therapy.
• Presence of any risk factor e.g.; smoker, pregnant and lactating patients.
• Previous history of periodontal surgical treatment in quadrant selected for the study.
• Restorations or caries in the area to be treated and non-vital tooth.
• Teeth which are tilted or rotated.
• Patients taking medications known to cause gingival enlargement.

Sponsors & Collaborators

• Hams Hamed Abdelrahman: lead

Study Sites (1)

Kafr El-sheikh University

Kafr Elsheikh, Egypt

Location

MeSH Terms

Conditions

Gingival Recession

Condition Hierarchy (Ancestors)

Gingival Diseases; Periodontal Diseases; Mouth Diseases; Stomatognathic Diseases; Periodontal Atrophy

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Lecturer of Dental Public Health and biostatistical consultanat

Study Record Dates

• First Submitted: March 8, 2026
• First Posted: March 12, 2026
• Study Start: March 1, 2024
• Primary Completion: September 1, 2025
• Study Completion: September 1, 2025
• Last Updated: March 12, 2026

Record last verified: 2026-03

Locations

EG (1)